Patent · US Active

Substituted arylcyclopentenes as therapeutic agents

US7713968B2 · kind B2 · utility

3Cited by

6References

12Claims

0Family size

Assignee

Allergan, Inc. · US

Inventors

Yariv Donde · Dana Point, US
Jeremiah H. Nguyen · La Puente, US

Key dates

Filing date	Apr 22, 2009
Grant date	May 11, 2010
Priority date	—
Expiry date	Apr 22, 2029

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P27/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds comprisingor a pharmaceutically acceptable salt or a prodrug thereof, are disclosed, wherein Y, A, and B are as described.Methods, compositions, and medicaments related thereto are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.